Stem reaffirms FY2026 revenue $140M-$190M while tracking toward high end of $10M-$15M adjusted EBITDA
Stem reaffirms its FY2026 revenue outlook at $140M-$190M and presents an adjusted EBITDA range with an upper projection of $10M-$15M.
The current price of $5.45 is positioned between the 20-day low of $4.92 and the high of $6.90, making it worth considering a rebound attempt near the resistance level. While there are concerns about short-term overheating due to the misalignment of moving averages and a decrease in trading volume ($0.72x), the potential for a news-based reevaluation may have prompted consideration for a staggered entry.
Take profit if the resistance level of $6.90 is breached, and cut losses if the support level of $4.92 is broken — the current price of $5.45 is within this range, making a staggered buying approach valid.
RSI(14) 48.0, moving averages are misaligned, trading volume is 0.72 times the 20-day average, recent 7-day volatility is +9.1%.
Due to the lack of past similar success cases or prior history for this stock, direct comparisons are difficult. However, after rechecking the news, it is worth referencing similar cases within the energy sector that exhibit short-term rebound patterns.
The actual return of 14.3% significantly exceeded the forecasted return of 2.5% — this appears to be due to weaker-than-expected selling pressure near the resistance level of $6.90, and the reaffirmation of news leading to a long-term reassessment of value. Despite technical weakness signals (moving average misalignment, low trading volume), a fundamental-based re-recognition has driven the stock price higher.
In the future, even if there are technical weakness signals, we will place more weight on the possibility of a news-based fundamental reassessment, adjusting the timing for incremental purchases and re-evaluating any stagnation or weak rebounds near resistance levels as entry opportunities — however, the stop-loss criteria will remain unchanged to continue managing downside risk.